FDA approves encorafenib with binimetinib for metastatic non-small cell lung cancer with a BRAF V600E mutation

FDA approves encorafenib with binimetinib for metastatic non-small cell lung cancer with a BRAF V600E mutation

http://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-encor...

Source: FDA Center for Drug Evaluation and Research - What's New - October 11, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Lung Cancer | Non-Small Cell Lung Cancer